Oak Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $793K | Sell |
1,510
-125
| -8% | -$65.6K | 0.28% | 66 |
|
|
2025
Q1 | $1.04M | Hold |
1,635
| – | – | 0.38% | 56 |
|
|
2024
Q4 | $1.16M | Hold |
1,635
| – | – | 0.43% | 55 |
|
|
2024
Q3 | $1.72M | Sell |
1,635
-150
| -8% | -$158K | 0.61% | 48 |
|
|
2024
Q2 | $1.88M | Sell |
1,785
-25
| -1% | -$26.3K | 0.69% | 45 |
|
|
2024
Q1 | $1.74M | Sell |
1,810
-50
| -3% | -$48.1K | 0.65% | 47 |
|
|
2023
Q4 | $1.63M | Sell |
1,860
-25
| -1% | -$22K | 0.65% | 46 |
|
|
2023
Q3 | $1.55M | Hold |
1,885
| – | – | 0.67% | 46 |
|
|
2023
Q2 | $1.35M | Hold |
1,885
| – | – | 0.56% | 49 |
|
|
2023
Q1 | $1.55M | Hold |
1,885
| – | – | 0.67% | 45 |
|
|
2022
Q4 | $1.36M | Sell |
1,885
-410
| -18% | -$296K | 0.61% | 46 |
|
|
2022
Q3 | $1.58M | Buy |
+2,295
| New | +$1.58M | 0.77% | 44 |
|
|
2022
Q2 | – | Sell |
-2,295
| Closed | -$1.6M | – | 142 |
|
|
2022
Q1 | $1.6M | Hold |
2,295
| – | – | 0.63% | 46 |
|
|
2021
Q4 | $1.45M | Hold |
2,295
| – | – | 0.55% | 49 |
|
|
2021
Q3 | $1.25M | Hold |
2,295
| – | – | 0.52% | 52 |
|
|
2021
Q2 | $1.28M | Buy |
+2,295
| New | +$1.28M | 0.54% | 50 |
|
|
2021
Q1 | – | Sell |
-2,295
| Closed | -$1.11M | – | 82 |
|
|
2020
Q4 | $1.11M | Hold |
2,295
| – | – | 0.54% | 47 |
|
|
2020
Q3 | $1.32M | Hold |
2,295
| – | – | 0.7% | 43 |
|
|
2020
Q2 | $1.43M | Hold |
2,295
| – | – | 0.85% | 40 |
|
|
2020
Q1 | $1.12M | Hold |
2,295
| – | – | 0.81% | 44 |
|
|
2019
Q4 | $862K | Hold |
2,295
| – | – | 0.48% | 52 |
|
|
2019
Q3 | $637K | Hold |
2,295
| – | – | 0.38% | 59 |
|
|
2019
Q2 | $681K | Buy |
+2,295
| New | +$681K | 0.42% | 58 |
|
|
2018
Q1 | – | Sell |
-745
| Closed | -$280K | – | 90 |
|
|
2017
Q4 | $280K | Buy |
+745
| New | +$280K | 0.21% | 76 |
|